USPTO serial 76311857
KARO BIO
Reviewed by CopyMark Law Group
Reg. 2950803Status 710
- Filing date
- Status date
- Registration date
- May 17, 2005
- Examiner
- FRENCH, CURTIS W
- Law office
- TMO LAW OFFICE 115
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with KARO BIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SE 141 57 Huddinge, SE
SE 141 57 Huddinge, SE
SE 141 57 Huddinge, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mainak H. Mehta
Mainak H. Mehta Procopio, Cory, Hargreaves and Savitch LLPSuite 2200525 B StreetSan Diego, CA 92101Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents for scientific or research use, namely, assays for identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances, such as enzymes or receptors, assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor, and tissue culture growth media; chemical preparations for use in medical research, namely, reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances such as enzymes or receptors; assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor; biochemicals for industrial purposes, namely, tissue culture growth media; chemical and biological substances for use in the manufacture of medicinal, pharmaceutical and veterinary products | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; pharmaceutical substances, namely dermatological creams for the treatment of skin disorders; veterinary preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; veterinary substances, namely, dermatological creams for use in the treatment of skin disorders, medicinal preparations for the treatment of metabolic disorders such as such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; medicinal substances, namely, dermatological cream for the treatment of skin disorders; medical diagnostic reagents; diagnostic agents for veterinary use; clinical medical reagents, namely, reagents for clinical-chemical tests; diagnostic reagents for clinical or medical laboratory use; vaccines; transdermal drug patches sold with medication for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, stroke, peripheral vascular disease, thromboembolism, retenosis of catheterization or surgical repairs, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; diagnostic kits for medical and veterinary purposes, namely, assays and reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity of biologically active substances, such as enzymes and receptors and to identify antibacterial compounds | SECTION 8 - CANCELLED | — |
| 010 | [Diagnostic apparatus for medical and veterinary purposes, namely, apparatus used in identifying compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity or biologically active substances, such as receptors and enzymes, and to identify antibacterial compounds] | SECTION 8 - CANCELLED | — |
| 042 | Pharmaceutical research services; pharmaceutical advisory services; scientific research project management; scientific and industrial research; medical laboratory services; medical research; provision of medical information; veterinary laboratory services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Karo Bio AB
- Other trademarks owned by Karo Bio AB
- Other trademarks owned by Karo Bio AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named KARO BIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 28, 2025 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| May 17, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jun 13, 2015 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jun 13, 2015 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Jun 13, 2015 | 9G8P | REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 | — |
| Jun 13, 2015 | 8PRT | REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED | — |
| Jun 13, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 23, 2015 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jan 5, 2012 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jan 5, 2012 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 5, 2012 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 17, 2011 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 17, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 7, 2005 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Apr 4, 2005 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Feb 22, 2005 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 30, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 10, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 29, 2004 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 24, 2004 | ALIE | ASSIGNED TO LIE | — |
| Sep 20, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2004 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Sep 15, 2004 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 13, 2004 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 24, 2004 | 44DD | SEC. 44(D) CLAIM DELETED | — |
| Jun 18, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 21, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 21, 2004 | PAPER RECEIVED | — | |
| Feb 9, 2004 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Jul 3, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| May 23, 2003 | CFIT | CASE FILE IN TICRS | — |
| May 14, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Mar 31, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Feb 24, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2002 | PAPER RECEIVED | — | |
| Jun 4, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 28, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 15, 2001 | DOCK | ASSIGNED TO EXAMINER | — |